LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results
Company Receives Approval to List on The NASDAQ Capital Market
SALT LAKE CITY, Sept. 10, 2012 -- LifeVantage Corporation, a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim®, the Nrf2 Synergizer®, today reported financial results for the fourth quarter and full year ended June 30, 2012.
Fiscal 2012 Fourth Quarter Highlights Compared to Same Period Last Year Include:
- Net revenue increased 197% to $44.6 million; - Operating margin increased to 16.5% compared to 13.0%; - Operating income grew 275% to $7.3 million.
Fiscal 2012 Full Year Highlights Compared to Fiscal 2011 Full Year Include:
- Net revenue increased 224% to $126.2 million; - Operating margin increased to 17.0% compared to 9.5%; - Operating income grew 480% to $21.5 million; - Cash and cash equivalents grew to $24.6 million as of June 30, 2012 from $6.4 million as of the prior year-end.
Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "We are pleased to report a strong fourth quarter and a record full year for fiscal 2012. Growing demand for and interest in our products combined with a stronger distributor base and infrastructure enabled us to increase our annual revenue by 224%, increase operating income by 480% and exceed the top end of our previously issued guidance range."
Mr. Robinson continued, "In fiscal 2012, we made strategic investments into our infrastructure and personnel in corporate administration, finance, marketing, operations, sales and R&D in order to put the necessary platform in place for us to continue our strong growth. As we begin fiscal 2013, we are excited about the opportunities ahead of us. In addition to continuing our strong organic growth in the core United States market, we plan to expand our international presence and enter new markets as well.
"Our financial and operating improvements in fiscal 2012 have also enabled us to achieve a listing on The NASDAQ Capital Market for our common stock. This event marks a major milestone in LifeVantage's history and will be an important step in achieving long-term shareholder value for our company."
Mr. Robinson concluded, "As we enter fiscal 2013, we believe we are well-positioned to deliver another record year of revenue and operating income growth. We look forward to updating you on our progress throughout this year."
NASDAQ Capital Market Listing
The Company announced today that its common stock has been approved for listing on The NASDAQ Capital Market. Shares of LifeVantage's common stock are expected to commence trading on the NASDAQ Capital Market under its current ticker symbol "LFVN," effective at market opening on September 12, 2012.
Fiscal Year 2013 Guidance
The Company anticipates continued strong growth in fiscal 2013. LifeVantage expects to generate revenue for fiscal 2013 in the range of $250 million to $260 million. The Company expects to generate operating income in the range of $34.5 million to $38.2 million, and an operating margin of 13.8% to 14.7%. The Company expects to generate earnings per diluted share in the range of $0.18 to $0.20, based on estimated weighted average diluted shares outstanding of 129 million.
Conference Call Information
The Company will hold an investor conference call today at 2:30 p.m. Mountain time (4:30 p.m. Eastern time). Investors interested in participating in the live call can dial (888) 587-0613 from the U.S. International callers can dial (719) 457-2710. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, September 12, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 8430189.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for approximately one year.
More LifeVantage News and Articles
- LifeVantage Appoints Charles J Wach COO
- LifeVantage Announces Protandim NRF1 Product Cyber Launch
- LifeVantage Launches PhysIQ Weight Management System
- LifeVantage Launches TrueScience Micro Lift Serum
- LifeVantage Launches Sports Science Lab With Real Salt Lake
- LifeVantage Appoints New CEO
- LifeVantage Launches Operations in Thailand
- LifeVantage Hosts Business Building Event for Women
- LifeVantage Announces Executive Management Change
- LifeVantage Named One of 100 Fastest Growing Companies in Utah
- LifeVantage Launches New Skin Care LIne
- LifeVantage Acquires New Product Line From Wicked Fast Sports Nutrition
- LifeVantage Recognized as Second Fastest Growing Company in Utah
- LifeVantage Awards 55 Jeeps to Top Distributors
- LifeVantage Expands International Operations in Canada
- LifeVantage Announces 3rd Quarter Fiscal 2013 Results
- LifeVantage Canine Health Earns Quality Seal from NASC
- LifeVantage Introduces Canine Health Product
- LifeVantage to Present at the Sidoti Semi-Annual Micro-Cap Conference
- LifeVantage Announces Shares Repurchase Program
- LifeVantage Corporation Announces Voluntary Recall
- LifeVantage to Present at the Wedbush 2012 California Dreamin Consumer Conference
- LifeVantage Lawsuit Dismissed
- LifeVantage Makes a Donation to the Against Malaria Foundation
- LifeVantage Announces First Quarter Fiscal Year 2013 Results
- LifeVantage Appoints New Chief Science Officer
- LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results
- LifeVantage Appoints David Colbert as New Chief Financial Officer
- LifeVantage Donates to Hunger Relief International
- LifeVantage Corporation Expands Management Team
- LifeVantage Announces Record Third Quarter Fiscal Year 2012
- LifeVantage Announces Market Expansion at Record Breaking Convention
- LifeVantage Makes Charitable Donation to Traffic Jam
- LifeVantage Featured in OTC Growth Stock Watch Newsletter
- LifeVantage Announces Record Second Quarter
- LifeVantage Spokesperson Donny Osmond Appears on Dr Phil Show
- LifeVantage to Announce Quarterly Results on February 14
- LifeVantage to Present at ICR XChange Conference
- LifeVantage Announces New Peer Reviewed Study
- LifeVantage Announces Record Fiscal Year
- LifeVantage At Accredited Members Conference
- LifeVantage Small Cap Equity Review
- LifeVantage Announces New President
- LifeVantage Dubs Protandim BSCG Approved
- LifeVantage Press Release
- LifeVantage Searches For New CEO
- LifeVantage CEO Refocuses On Marketing Channel
- LifeVantage Press Release
- LifeVantage Announces Board Expansion
- Mexican government approves LifeVantage Protandim
- LifeVantage Announces First Quarter Revenue
- LifeVantage Announces 4th Quarter 2009 Results
- LifeVantage granted third patent for Protandim
- LifeVantage Trims Operating Costs
- LifeVantage Signs Agreement with Montel Williams
- LifeVantage Makes Record Setting Announcement
- LifeVantage to Present at ROTH Capital Partners
- LifeVantage PR Claims Protandim Results
- LifeVantage Shows Loss for Year
- LiveVantage Announces Protandim Sales Increase
- LifeVantage Appoints Richard Doutre Jones
- LifeVantage Expands Global Marketing Initiatives
- LiveVantage Announces Asia Market Expansion
- LifeVantage Announces 2Q 2007 Financials
- Brown Named CEO of LifeVantage
LifeVantage Profile
Create a Free LifeVantage Rep Listing
